Skip to main content
Top
Published in: Rheumatology International 1/2007

01-11-2007 | Case Report

A case of Budd–Chiari syndrome with Behcet’s disease and oral contraceptive usage

Authors: Türkay Akbaş, Neşe İmeryüz, Fatih Bayalan, Feyyaz Baltacıoğlu, Pamir Atagündüz, Lütfiye Mülazımoğlu, Haner Direskeneli

Published in: Rheumatology International | Issue 1/2007

Login to get access

Abstract

We present a case of Budd–Chiari syndrome (BCS) having two risk factors, Behcet’s disease (BD) and oral contraceptive (OC) usage. A 33-year-old woman with BD was admitted to the Emergency Unit with nausea, vomiting, abdominal pain, abdominal distention, and confusion started 12 days ago before admission. Since the patient was in a shock state, she was taken to the Intensive Care Unit (ICU) with the suspicion of abdomen-originated sepsis. Abdominal ultrasound showed massive hepatosplenomegaly and moderate ascites. Abdominal MRI revealed an inferior vena cava (IVC) obstruction starting above the renal veins and diffuse thrombosis of the right and medial hepatic veins. An extensive thrombosis of the IVC and the hepatic veins (BCS) which led to shock was diagnosed. In addition to BD, the unnotified OC usage for a year by the patient without her doctor’s knowledge was recognized as possible precipitating factor of BCS. Pulse methylprenisolone was started for three consecutive days to treat active BD-induced vasculitis. IVC digital subtraction angiography (DSA) showed occlusion of the IVC below the hepatic veins with extensive collateral circulation originating at the occlusion level suggesting that obliteration had a subacute or chronic course. Since intralesional thrombolytic therapy failed, the patient was transferred to a liver transplantation center. While waiting for an appropriate donor, the patient died due to hepatic failure. Since BCS is mortal and deemed multi-factorial, every patient with a thrombotic risk factor such as BD should be questioned for other possible causes of thrombosis.
Literature
1.
go back to reference Bayraktar Y, Harmancı O (2006) Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol 12(8):1165–1174PubMed Bayraktar Y, Harmancı O (2006) Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol 12(8):1165–1174PubMed
2.
go back to reference Bogin V, Marcos A, Shaw-Stiffel T (2005) Budd–Chiari syndrome: in evaluation. Eur J Gastroenterol Hepatol 17:33–35PubMedCrossRef Bogin V, Marcos A, Shaw-Stiffel T (2005) Budd–Chiari syndrome: in evaluation. Eur J Gastroenterol Hepatol 17:33–35PubMedCrossRef
3.
go back to reference International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078–1080
4.
go back to reference Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akaya S (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19(3):402–410PubMed Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akaya S (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19(3):402–410PubMed
5.
go back to reference Bismuth E, Hadengue A, Hammel P, Benhamou JP (1990) Hepatic vein thrombosis in Behçet’s disease. Hepatology 11(6):969–974PubMedCrossRef Bismuth E, Hadengue A, Hammel P, Benhamou JP (1990) Hepatic vein thrombosis in Behçet’s disease. Hepatology 11(6):969–974PubMedCrossRef
6.
go back to reference Calamia KT, Schirmer M, Melikoglu M (2005) Major vessel involvement in Behçet’s disease. Curr Opin Rheumatol 17:1–8PubMedCrossRef Calamia KT, Schirmer M, Melikoglu M (2005) Major vessel involvement in Behçet’s disease. Curr Opin Rheumatol 17:1–8PubMedCrossRef
7.
go back to reference Bayraktar Y, Balkanci F, Kansu E, Kayhan B, Arslan S, Eryilmaz M, Telatar H (1993) Budd–Chiari syndrome: analysis of 30 cases. Angiology 44(7):541–551PubMedCrossRef Bayraktar Y, Balkanci F, Kansu E, Kayhan B, Arslan S, Eryilmaz M, Telatar H (1993) Budd–Chiari syndrome: analysis of 30 cases. Angiology 44(7):541–551PubMedCrossRef
8.
go back to reference Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd–Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenerol 92(5):858–862 Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd–Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenerol 92(5):858–862
9.
go back to reference Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP (2004) Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol 40(1):172–180PubMedCrossRef Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP (2004) Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol 40(1):172–180PubMedCrossRef
10.
go back to reference Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Papliuca A, O’Grady J, Heaton N (2002) Liver transplantation for Budd–Chiari syndrome. Transplantation 73:973–977PubMedCrossRef Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Papliuca A, O’Grady J, Heaton N (2002) Liver transplantation for Budd–Chiari syndrome. Transplantation 73:973–977PubMedCrossRef
11.
go back to reference Almer S, Bodemar G, Ryden BO, Elfstrom J, Franzen L, Ihse I, Resjo M (1989) Oral contraceptives and blood diseases are the most common causes of Budd–Chiari syndrome. Lakartidnigen 86(46):4002–4008 Almer S, Bodemar G, Ryden BO, Elfstrom J, Franzen L, Ihse I, Resjo M (1989) Oral contraceptives and blood diseases are the most common causes of Budd–Chiari syndrome. Lakartidnigen 86(46):4002–4008
12.
go back to reference Maddrey WC (1987) Hepatic vein thrombosis (Budd–Chiari syndrome): Possible association with the use of oral contraceptives. Semin Liver Dis 7(1):32–39PubMedCrossRef Maddrey WC (1987) Hepatic vein thrombosis (Budd–Chiari syndrome): Possible association with the use of oral contraceptives. Semin Liver Dis 7(1):32–39PubMedCrossRef
13.
go back to reference Minnema MC, Janssen HLA, Niermeijer P, de Man RA, et al (2000) Budd–Cihari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatology 33:509–512CrossRef Minnema MC, Janssen HLA, Niermeijer P, de Man RA, et al (2000) Budd–Cihari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatology 33:509–512CrossRef
14.
go back to reference Li XM, Wei YF, Hao HL, Hao YB, He LS, Li JD (2002) Hyperhomocysteinemia and the MTHFR C677T mutation in Budd–Chiari syndrome. Am J Hematol 71:11–14PubMedCrossRef Li XM, Wei YF, Hao HL, Hao YB, He LS, Li JD (2002) Hyperhomocysteinemia and the MTHFR C677T mutation in Budd–Chiari syndrome. Am J Hematol 71:11–14PubMedCrossRef
15.
go back to reference Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453–1457PubMedCrossRef Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453–1457PubMedCrossRef
16.
go back to reference Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Büller HR, Vanderbroucke JP (1995) Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 346:1593–1596PubMedCrossRef Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Büller HR, Vanderbroucke JP (1995) Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 346:1593–1596PubMedCrossRef
17.
go back to reference Deninger M-H, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587–591CrossRef Deninger M-H, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587–591CrossRef
Metadata
Title
A case of Budd–Chiari syndrome with Behcet’s disease and oral contraceptive usage
Authors
Türkay Akbaş
Neşe İmeryüz
Fatih Bayalan
Feyyaz Baltacıoğlu
Pamir Atagündüz
Lütfiye Mülazımoğlu
Haner Direskeneli
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0377-7

Other articles of this Issue 1/2007

Rheumatology International 1/2007 Go to the issue

Acknowledgement to Referees

Referees 2006